http://www.reportbuyer.com/rss.htmlStay ahead of the competition with our catalogue of Aids & HIV reports in Pharma & Healthcare. Reports include data on Europe, UK, USA, Asia and other global markets. en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/hiv_market_forecast.htmlIn 2008, antiretroviral sales across the seven major markets totaled $10. 7 billion, growing at a CAGR of 12. 8% between 2005 and 2008. 5dbf3b91a601e703ad392db265557508Sat, 06 Jun 2009 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/forecast_insight_hiv.htmlIn 2008, antiretroviral sales across the seven major markets totaled $10. 7 billion, growing at a CAGR of 12. 8% between 2005 and 2008. b3ddd96db7c8e79c16c92d0006c2b905Sat, 06 Jun 2009 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/european_hiv_aids_therapeutics_markets.htmlThis research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the current and future trends in the European market. f77c169817162311d10d1fd7ce62f75eSat, 04 Apr 2009 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/global_hiv_market_analysis.htmlHIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment for HIV which has made a separate market for HIV drugs. The HIV drug market is increasing due to increasing awareness and diagnosis rates. 87ed0c18669ff669223825284e3b628fMon, 02 Feb 2009 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/pipeline_insight_hiv.html Treatment of HIV has come a long way since the discovery of the virus. Although no real cure has been found yet, the last few decades have seen the introduction of many classes of drugs that suppress the replication of the virus. As therapeutics have improved dramatically in terms of efficacy, safety and convenience, the bar for new drugs has been raised considerably. 9f1a22b5097d6e79bfa7327d0d1fa582Wed, 19 Dec 2007 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/chinese_markets_hiv_treatment_drugs.htmlChina's demand for HIV treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. f91efc8179d4d7b567f38bb3635c05bdSat, 01 Sep 2007 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/commercial_insight_hiv_reshaping_treatment_paradigms.html Detailed analysis of the antiretroviral therapy market. 10 year sales forecast for marketed drugs and key pipeline compounds, factoring in clinical trial results, new product launches and patent expiries. In-depth analysis of the current HIV market across the major US and EU markets Thorough assessment of underlying commercial and clinical factors shaping the antiretroviral market Detailed sales forecasts for the three major antiretroviral classes, molecules and brands in each of the six major markets Case study analysis of the entry inhibitor class focusing on the competitive environment and critical success factors By 2016 the HIV market is forecasted to grow to $11. cf5f00ab50d8caae64ebadae3cc1d074Wed, 11 Jul 2007 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/global_hiv_aids_market_outlook_2012.htmlBusiness Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports are designed to help you make well informed and timely business decisions. We understand the problems facing today's pharmaceutical and healthcare executives when trying to drive your business forward, and appreciate the importance of accurate, up-to-date, incisive product, market and company analysis. We help you to crystallize your business decisions. 828c59e89c8e77aa1167b53d120fd668Sun, 01 Jul 2007 12:00:00 GBDiseases/AIDS & HIVhttp://www.reportbuyer.com/pharma_healthcare/diseases/aids_hiv/hiv_strategic_analysis_therapeutic_testing_markets.htmlThe strategic interplay of of HIV/AIDS diagnostics and therapeutics is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS, companies must think on a global basis, and in addition to the basic pathology and complications of HIV/AIDS, there are societal and ethical pressures, geopolitical factors, and evolving marketplace disruptions. For the development of a coherent strategy in this therapeutic area, companies must clearly focus on three primary areas, the first of which is strongly influenced by the latter two: market potential, epidemiology (including HIV/AIDS patient trends) and the current and emerging technologies in both diagnostics and therapeutics. 5fa12e7f3e53caa8f16d986c2904bbdaWed, 01 Mar 2006 12:00:00 GBDiseases/AIDS & HIV